Inflammatory Bowel Disease Relief Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Aminosalicyclates, Immunomodulators, TNF Inhibitors, Corticosteroids); Indication (Crohn's Disease, Ulcerative Colitis); Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Report Code: TIPRE00014264 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Inflammatory bowel disease (IBD) is chronic inflammation of the digestive tract. The two types of IBD are ulcerative colitis and Crohn's disease that usually involve severe diarrhea, abdominal pain, fatigue and weight loss. The treatment of the IBD is to reduce the inflammation that triggers your signs and symptoms. The treatment involves the drug therapy or surgery.

MARKET DYNAMICS

The inflammatory bowel disease relief market is driving due to increase in intake of unhealthy food and beverages along with the stressful lifestyle. However, lack of adoption in emerging countries is expected to hamper the growth of the global Inflammatory Bowel Disease Relief market. Moreover, strong pipeline products for the treatment of inflammatory bowel disease (IBD) is anticipated to drive demand the growth of the market.

MARKET SCOPE

The "Inflammatory Bowel Disease Relief Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of inflammatory bowel disease relief market with detailed market segmentation by drug class, indication, and distribution channel. The inflammatory bowel disease relief market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in inflammatory bowel disease relief market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The inflammatory bowel disease relief market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market is segmented into aminosalicyclates, immunomodulators, TNF inhibitors, corticosteroids. Based on indication, the market is segmented into Crohn's disease, and ulcerative colitis. Based on distribution channel, the market is segmented into hospital pharmacy, online pharmacy, retail pharmacy.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the inflammatory bowel disease relief market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The inflammatory bowel disease relief market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting inflammatory bowel disease relief market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the inflammatory bowel disease relief market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the inflammatory bowel disease relief market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from inflammatory bowel disease relief market are anticipated to have lucrative growth opportunities in the future with the rising demand for inflammatory bowel disease relief market in the global market. Below mentioned is the list of few companies engaged in the inflammatory bowel disease relief market.

The report also includes the profiles of key players in inflammatory bowel disease relief market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Johnson and Johnson Services, Inc.
  •   Pfizer Inc.
  •   AbbVie Inc.
  •   Takeda Pharmaceutical Company Limited
  •   Celltrion Healthcare
  •   CELGENE CORPORATION
  •   Cosmo Pharmaceuticals N.V.
  •   Gilead Sciences, Inc.
  •   Meters Biopharma

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Inflammatory Bowel Disease Relief Market - By Drug Class
1.3.2 Inflammatory Bowel Disease Relief Market - By Indication
1.3.3 Inflammatory Bowel Disease Relief Market - By Distribution Channel
1.3.4 Inflammatory Bowel Disease Relief Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFLAMMATORY BOWEL DISEASE RELIEF MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFLAMMATORY BOWEL DISEASE RELIEF MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFLAMMATORY BOWEL DISEASE RELIEF MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLAMMATORY BOWEL DISEASE RELIEF - GLOBAL MARKET OVERVIEW
6.2. INFLAMMATORY BOWEL DISEASE RELIEF - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INFLAMMATORY BOWEL DISEASE RELIEF MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. AMINOSALICYCLATES
7.3.1. Overview
7.3.2. Aminosalicyclates Market Forecast and Analysis
7.4. IMMUNOMODULATORS
7.4.1. Overview
7.4.2. Immunomodulators Market Forecast and Analysis
7.5. TNF INHIBITORS
7.5.1. Overview
7.5.2. TNF Inhibitors Market Forecast and Analysis
7.6. CORTICOSTEROIDS
7.6.1. Overview
7.6.2. Corticosteroids Market Forecast and Analysis
8. INFLAMMATORY BOWEL DISEASE RELIEF MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. CROHN'S DISEASE
8.3.1. Overview
8.3.2. Crohn's Disease Market Forecast and Analysis
8.4. ULCERATIVE COLITIS
8.4.1. Overview
8.4.2. Ulcerative Colitis Market Forecast and Analysis
9. INFLAMMATORY BOWEL DISEASE RELIEF MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACY
9.3.1. Overview
9.3.2. Hospital Pharmacy Market Forecast and Analysis
9.4. ONLINE PHARMACY
9.4.1. Overview
9.4.2. Online Pharmacy Market Forecast and Analysis
9.5. RETAIL PHARMACY
9.5.1. Overview
9.5.2. Retail Pharmacy Market Forecast and Analysis
10. INFLAMMATORY BOWEL DISEASE RELIEF MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Inflammatory Bowel Disease Relief Market Overview
10.1.2 North America Inflammatory Bowel Disease Relief Market Forecasts and Analysis
10.1.3 North America Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Drug Class
10.1.4 North America Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Indication
10.1.5 North America Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Countries
10.1.6.1 United States Inflammatory Bowel Disease Relief Market
10.1.6.1.1 United States Inflammatory Bowel Disease Relief Market by Drug Class
10.1.6.1.2 United States Inflammatory Bowel Disease Relief Market by Indication
10.1.6.1.3 United States Inflammatory Bowel Disease Relief Market by Distribution Channel
10.1.6.2 Canada Inflammatory Bowel Disease Relief Market
10.1.6.2.1 Canada Inflammatory Bowel Disease Relief Market by Drug Class
10.1.6.2.2 Canada Inflammatory Bowel Disease Relief Market by Indication
10.1.6.2.3 Canada Inflammatory Bowel Disease Relief Market by Distribution Channel
10.1.6.3 Mexico Inflammatory Bowel Disease Relief Market
10.1.6.3.1 Mexico Inflammatory Bowel Disease Relief Market by Drug Class
10.1.6.3.2 Mexico Inflammatory Bowel Disease Relief Market by Indication
10.1.6.3.3 Mexico Inflammatory Bowel Disease Relief Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Inflammatory Bowel Disease Relief Market Overview
10.2.2 Europe Inflammatory Bowel Disease Relief Market Forecasts and Analysis
10.2.3 Europe Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Indication
10.2.5 Europe Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Inflammatory Bowel Disease Relief Market
10.2.6.1.1 Germany Inflammatory Bowel Disease Relief Market by Drug Class
10.2.6.1.2 Germany Inflammatory Bowel Disease Relief Market by Indication
10.2.6.1.3 Germany Inflammatory Bowel Disease Relief Market by Distribution Channel
10.2.6.2 France Inflammatory Bowel Disease Relief Market
10.2.6.2.1 France Inflammatory Bowel Disease Relief Market by Drug Class
10.2.6.2.2 France Inflammatory Bowel Disease Relief Market by Indication
10.2.6.2.3 France Inflammatory Bowel Disease Relief Market by Distribution Channel
10.2.6.3 Italy Inflammatory Bowel Disease Relief Market
10.2.6.3.1 Italy Inflammatory Bowel Disease Relief Market by Drug Class
10.2.6.3.2 Italy Inflammatory Bowel Disease Relief Market by Indication
10.2.6.3.3 Italy Inflammatory Bowel Disease Relief Market by Distribution Channel
10.2.6.4 Spain Inflammatory Bowel Disease Relief Market
10.2.6.4.1 Spain Inflammatory Bowel Disease Relief Market by Drug Class
10.2.6.4.2 Spain Inflammatory Bowel Disease Relief Market by Indication
10.2.6.4.3 Spain Inflammatory Bowel Disease Relief Market by Distribution Channel
10.2.6.5 United Kingdom Inflammatory Bowel Disease Relief Market
10.2.6.5.1 United Kingdom Inflammatory Bowel Disease Relief Market by Drug Class
10.2.6.5.2 United Kingdom Inflammatory Bowel Disease Relief Market by Indication
10.2.6.5.3 United Kingdom Inflammatory Bowel Disease Relief Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Inflammatory Bowel Disease Relief Market Overview
10.3.2 Asia-Pacific Inflammatory Bowel Disease Relief Market Forecasts and Analysis
10.3.3 Asia-Pacific Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Inflammatory Bowel Disease Relief Market
10.3.6.1.1 Australia Inflammatory Bowel Disease Relief Market by Drug Class
10.3.6.1.2 Australia Inflammatory Bowel Disease Relief Market by Indication
10.3.6.1.3 Australia Inflammatory Bowel Disease Relief Market by Distribution Channel
10.3.6.2 China Inflammatory Bowel Disease Relief Market
10.3.6.2.1 China Inflammatory Bowel Disease Relief Market by Drug Class
10.3.6.2.2 China Inflammatory Bowel Disease Relief Market by Indication
10.3.6.2.3 China Inflammatory Bowel Disease Relief Market by Distribution Channel
10.3.6.3 India Inflammatory Bowel Disease Relief Market
10.3.6.3.1 India Inflammatory Bowel Disease Relief Market by Drug Class
10.3.6.3.2 India Inflammatory Bowel Disease Relief Market by Indication
10.3.6.3.3 India Inflammatory Bowel Disease Relief Market by Distribution Channel
10.3.6.4 Japan Inflammatory Bowel Disease Relief Market
10.3.6.4.1 Japan Inflammatory Bowel Disease Relief Market by Drug Class
10.3.6.4.2 Japan Inflammatory Bowel Disease Relief Market by Indication
10.3.6.4.3 Japan Inflammatory Bowel Disease Relief Market by Distribution Channel
10.3.6.5 South Korea Inflammatory Bowel Disease Relief Market
10.3.6.5.1 South Korea Inflammatory Bowel Disease Relief Market by Drug Class
10.3.6.5.2 South Korea Inflammatory Bowel Disease Relief Market by Indication
10.3.6.5.3 South Korea Inflammatory Bowel Disease Relief Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Inflammatory Bowel Disease Relief Market Overview
10.4.2 Middle East and Africa Inflammatory Bowel Disease Relief Market Forecasts and Analysis
10.4.3 Middle East and Africa Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Inflammatory Bowel Disease Relief Market
10.4.6.1.1 South Africa Inflammatory Bowel Disease Relief Market by Drug Class
10.4.6.1.2 South Africa Inflammatory Bowel Disease Relief Market by Indication
10.4.6.1.3 South Africa Inflammatory Bowel Disease Relief Market by Distribution Channel
10.4.6.2 Saudi Arabia Inflammatory Bowel Disease Relief Market
10.4.6.2.1 Saudi Arabia Inflammatory Bowel Disease Relief Market by Drug Class
10.4.6.2.2 Saudi Arabia Inflammatory Bowel Disease Relief Market by Indication
10.4.6.2.3 Saudi Arabia Inflammatory Bowel Disease Relief Market by Distribution Channel
10.4.6.3 U.A.E Inflammatory Bowel Disease Relief Market
10.4.6.3.1 U.A.E Inflammatory Bowel Disease Relief Market by Drug Class
10.4.6.3.2 U.A.E Inflammatory Bowel Disease Relief Market by Indication
10.4.6.3.3 U.A.E Inflammatory Bowel Disease Relief Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Inflammatory Bowel Disease Relief Market Overview
10.5.2 South and Central America Inflammatory Bowel Disease Relief Market Forecasts and Analysis
10.5.3 South and Central America Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Inflammatory Bowel Disease Relief Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Inflammatory Bowel Disease Relief Market
10.5.6.1.1 Brazil Inflammatory Bowel Disease Relief Market by Drug Class
10.5.6.1.2 Brazil Inflammatory Bowel Disease Relief Market by Indication
10.5.6.1.3 Brazil Inflammatory Bowel Disease Relief Market by Distribution Channel
10.5.6.2 Argentina Inflammatory Bowel Disease Relief Market
10.5.6.2.1 Argentina Inflammatory Bowel Disease Relief Market by Drug Class
10.5.6.2.2 Argentina Inflammatory Bowel Disease Relief Market by Indication
10.5.6.2.3 Argentina Inflammatory Bowel Disease Relief Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INFLAMMATORY BOWEL DISEASE RELIEF MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INFLAMMATORY BOWEL DISEASE RELIEF MARKET, KEY COMPANY PROFILES
13.1. JOHNSON AND JOHNSON SERVICES, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PFIZER INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ABBVIE INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TAKEDA PHARMACEUTICAL COMPANY LIMITED
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CELLTRION HEALTHCARE
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. CELGENE CORPORATION
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. COSMO PHARMACEUTICALS N.V.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. GILEAD SCIENCES, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. METERS BIOPHARMA
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Johnson and Johnson Services, Inc.
2. Pfizer Inc.
3. AbbVie Inc.
4. Takeda Pharmaceutical Company Limited
5. Celltrion Healthcare
6. CELGENE CORPORATION
7. Cosmo Pharmaceuticals N.V.
8. Gilead Sciences, Inc.
9. Meters Biopharma
TIPRE00014264
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking